Korea Biotech Q3 Roundup: R&D Strategies Modified As Firms Select And Focus
Realigning Priorities In Challenging Environment
Scrip takes a look at major R&D trends in the Korean biotech sector in the third quarter, analysing new moves at Genexine, Bridge Biotherapeutics, Oscotec and others to cope with ongoing challenges and focus resources on the most promising projects.
